Abstract

In randomized controlled trials, intention-to-treat analysis is customarily used to estimate the effect of the trial. However, in the presence of noncompliance, this can often lead to biased estimates because intention-to-treat analysis completely ignores varying levels of actual treatment received. This is a known issue that can be overcome by adopting the complier average causal effect approach, which estimates the effect the trial had on the individuals who complied with the protocol. When compliance is unobserved in the control group, the complier average causal effect estimate can be obtained via a latent class specification using the gsem command.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call